DMC
DMC (DMC) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 57,500 VND, little changed on the session, giving a market capitalization of 2.0 trillion VND.
On valuation, DMC trades at a price-to-earnings ratio of 9.9 and a price-to-book of 1.2. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 11.7% points to modest profitability relative to the company's equity base. Trailing earnings per share stand at 5,872 VND.
Aveluro tracks 9 news items mentioning DMC. The most recent catalyst was a dividend announcement event — "DMC Announces 25% Cash Dividend for 2025, Record Date Sept 15". Aveluro's composite model rates DMC 6.4/10 (Neutral), blending news sentiment, price momentum, and fundamentals.
Comparable names in the Health Care sector include AGP, AMP and AMV.
DMC Announces 25% Cash Dividend for 2025, Record Date Sept 15
Recent developments around DMC include 5 notable classified events. On Aug 24, 2026, a dividend announcement was reported: Domesco (DMC) will pay a 25% cash dividend for 2025, equivalent to 2,500 VND per share, with payment on October 21 and a record date of September 15. On Aug 24, 2026, a dividend announcement was reported: DMC (HOSE) declares a 25% cash dividend for 2025, payable October 21, 2026, with record date September 15, 2025. On Aug 13, 2026, a market event was reported: SCIC's 2026-2030 restructuring plan targets full divestment from 66 enterprises, potentially adding significant supply to the market, while retaining stakes in 21 firms including Vinamilk (VNM), Sabeco (SAB), and FPT. On Aug 13, 2026, a macro policy event was reported: KBSV identifies 13 companies in the state divestment pipeline under Decision 40, with notable planned reductions at BCM, BSR, and GAS, and full divestment for MSB, NTP, HND, QTP, VGC, PVI, and DMC. On May 13, 2026, a market event was reported: Vietnam's top three pharma companies by market cap—DHG, IMP, and DHT—are now under foreign control or significant influence, with Taisho, Livzon, and ASKA as key shareholders.
The overall tone of recent coverage is positive, with 2 of 5 events carrying bullish sentiment.
By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this